Cargando…
Low risk of transmission of SARS-CoV2 and effective endotherapy for gastrointestinal bleeding despite challenges supports resuming optimum endoscopic services
Autores principales: | Agarwal, Ashish, Chowdhury, Sudipta Dhar, Sachdeva, Sanjeev, Saraswat, Vivek, Kochhar, Rakesh, Saraya, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556781/ https://www.ncbi.nlm.nih.gov/pubmed/33129713 http://dx.doi.org/10.1016/j.dld.2020.10.009 |
Ejemplares similares
-
Endotherapy for pancreatic necrosis: An update
por: Jha, Ashish K, et al.
Publicado: (2018) -
Waiting times for endotherapy of early malignancy: No problem?
por: Ehlken, Hanno, et al.
Publicado: (2020) -
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
por: Riario Sforza, Gian Galeazzo, et al.
Publicado: (2018) -
Efficacy of Pancreatic Endotherapy in Pancreatic Ascites and Pleural Effusion
por: Gupta, Sudhir, et al.
Publicado: (2017) -
Clinical Profile, Etiology and Role of Endotherapy in Chronic Calcific Pancreatitis: An Experience from North India
por: Yattoo, G N, et al.
Publicado: (2023)